The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with Peptide Blends at the Perito Clinic The Perito Clinic The Peptide Craze Ground Truths TB 500 Exposed: The Risks Outweigh the Benefits